Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Allotment
We wish to inform that Rights Issue Committee of the Board has allotted 1,19,98,755 shares pursuant to Rights issue at its meeting held on June 19, 2024. Solara Active Pharma Sciences Ltd - 541540 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 13, 2024 for Pronomz Ventures LLP Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 13, 2024 for Pronomz Ventures LLP Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release titled "Solara announces closure of Rights Issue" Solara Active Pharma Sciences Ltd - 541540 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 10, 2024 for SRJR Enterprise LLP & PACs Solara Active Pharma Sciences Ltd - 541540 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 10, 2024 for SRJR Enterprise LLP & Others Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 10, 2024 for SRJR Enterprise LLP & PACs Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 10, 2024 for SRJR Enterprise LLP & PACs Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings conference call held for the quarter ended March 31, 2024 Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for the Consolidated Financial Results